Life Scientist > Lab Technology

WEHI receives $450,000 from VCA

05 August, 2010 by Staff Writers

The Walter and Eliza Hall Institute (WEHI) has received grants totalling $450,000 from the Victorian Cancer Agency to support its research into BH3 mimetics cancer drugs and the creation of an information sharing portal focussed on rare cancers.


Patrys to receive funding of $15 million

03 August, 2010 by David Binning

Melbourne biotech Patrys announced today that it has secured funding of up to $15 million over the next three years to develop its lead natural human anti-body candidates into treatments for various cancers.


Sigma names Jeff Sells as company CFO

28 July, 2010 by David Binning

Beleaguered Victorian biotech Sigma Pharmaceuticals has appointed former group treasurer Jeff Sells as its new CFO.


Young 2010 Garvan Fellows named

27 July, 2010 by Staff Writers

The Garvan Institute has named two of its top upcoming scientists as Young 2010 Garvan Fellows with each to receive a grant of $25,000 to advance their research looking into treatments for cancer and diabetes.


How music makes you smarter

19 July, 2010 by Staff Writers

Music training may bring about biological changes in the brain that could enhance music processing and even transfer to other domains.


Australia to host 19th World Congress of Soil Science

16 July, 2010 by Staff Writers

More than 2000 of the world’s leading experts on soil will converge on Brisbane next month for the 19th World Congress of Soil Science.


Life Sciences sector down for Q4 but ahead of wider market: PWC

15 July, 2010 by David Binning

PricewaterhouseCoopers has released its BioForum report for the fourth quarter FY10 showing a fall of 9.5 percent for the local Life Sciences Index, which performed slightly better than the broader market.


Sigma rejects revised offer from Aspen

12 July, 2010 by Staff Writers

Melbourne biotech Sigma Pharmaceuticals has assured shareholders that it is trying to negotiate a better deal than the revised $0.55 a share offered for the company by South African generics producer Aspen Pharmacare Holdings.


Lack of R&D output a worrying sign for big pharma

02 July, 2010 by Staff Writers

Pharmaceutical companies continue to be heavily reliant on sales form their mature drugs, while investment in R&D and clinical trials for their successors has shown a marked decline.


Sydney research centre to nurture U.S approaches to innovation

02 July, 2010 by Staff Writers

Merck has stumped up $500,000 to fund a new research centre at the University of Sydney designed to help Australia benefit from U.S approaches to innovation.


Majors help deliver strong quarter for Australian life sciences: PWC

02 July, 2010 by Staff Writers

Price Waterhouse Coopers has released its quarterly Bioforum report showing that the Australian life sciences sector is outperforming the wider market despite a fairly slow start to the year.


MP Biomedicals buys NZ’s ICPBio

29 June, 2010 by David Binning

California’s MP Biomedicals has acquired the assets of Auckland-based protein biologics manufacturing company ICPbio in deal estimated to be worth.


Government seeking to apply R&D Tax Credit retrospectively from July 1 this year

29 June, 2010 by David Binning

Federal innovation minister Kim Carr has affirmed that the government will seek to have its new R&D Tax Credit apply retrospectively from July 1 this year.


Roundtable: from innovation to commercialisation - Part III: closing comments

28 June, 2010 by Tim Dean

In this final part of the roundtable discussion the panellists address the role of government in commercialisation and then provide their closing comments on how we can improve the system in Australia.


Research committee named for SAHMRI

22 June, 2010 by David Binning

A who’s who of Australian scientists have been tapped to direct the research of the new South Australian Health and Medical Research Institute (SAHMRI) in Adelaide.


  • All content Copyright © 2022 Westwick-Farrow Pty Ltd